Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$15.83 -0.12 (-0.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) Cost of Revenue (2021 - 2026)

Updated

Aurinia Pharmaceuticals (AUPH) recorded Cost of Revenue of $6.56 million in Q2 2026, down 7.9% from $7.12 million a year earlier but up 0.8% from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) Cost of Revenue (2021 - 2026) Analysis & Trends

On a TTM basis, Aurinia Pharmaceuticals' Cost of Revenue came in at $30.04 million as of Jun 30, 2026, up 10.1% year-over-year; for FY2025, it was $32.67 million, up 15.6% from FY2024.

  • Annual Cost of Revenue has increased for four straight years, with a four-year compound annual growth rate of 133.9% (FY2021 to FY2025).
  • Across earlier years, Cost of Revenue came in at $28.25 million in FY2024 (+99.7%), $14.15 million in FY2023 (+149.8%), $5.66 million in FY2022 (+419.2%) and $1.09 million in FY2021.
  • Quarterly Cost of Revenue has ranged from $254,000 in Q3 2021 to $8.91 million in Q2 2024 over the past five years.
  • On a year-over-year basis, Cost of Revenue rose in four of the last eight quarters, with growth averaging 5.6%.
  • Peak year-over-year performance for Cost of Revenue in the last five years was growth of 863.4% in Q3 2022, against a decline of 24.1% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.51 million (Q1 2026), $8.8 million (Q4 2025) and $8.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Aurinia Pharmaceuticals 2.10 Bn 532.21 Mn 76.67 Mn 6.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.56 Mn
Mar 31, 2026 6.51 Mn
Dec 31, 2025 8.80 Mn
Sep 30, 2025 8.18 Mn
Jun 30, 2025 7.12 Mn
Mar 31, 2025 8.57 Mn
Dec 31, 2024 5.55 Mn
Sep 30, 2024 6.04 Mn
Jun 30, 2024 8.91 Mn
Mar 31, 2024 7.75 Mn
Dec 31, 2023 5.40 Mn
Sep 30, 2023 6.77 Mn
Jun 30, 2023 1.56 Mn
Mar 31, 2023 421,000.00
Dec 31, 2022 1.36 Mn
Sep 30, 2022 2.45 Mn
Jun 30, 2022 1.60 Mn
Mar 31, 2022 256,000.00
Dec 31, 2021 481,000.00
Sep 30, 2021 254,000.00
API Access

Aurinia Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AUPH&period=max&api_key=YOUR_API_KEY